1 / 1

100

A. *. *. STC-1. *. BON. 150. caspase-3 activity [% of control]. 100. 50. 0. 10. 250. 50 0. 100. IFN  [U/ml]. B. BON. 200. *. 150. *. caspase-3 activity [% of control]. 100. 50. 0. IFN  (10U/ml) + MIBG (10µM). 10. 100. 10. 20. MIBG [µM]. IFN  [U/ml].

marc
Télécharger la présentation

100

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A * * STC-1 * BON 150 caspase-3 activity [% of control] 100 50 0 10 250 500 100 IFN [U/ml] B BON 200 * 150 * caspase-3 activity [% of control] 100 50 0 IFN (10U/ml) + MIBG (10µM) 10 100 10 20 MIBG [µM] IFN [U/ml] IFN (10U/ml) + MIBG (20µM) IFN (100U/ml) + MIBG (10µM) IFN (100U/ml) + MIBG (20µM) C STC-1 * 150 100 caspase-3 activity [% of control] 50 0 IFN (10U/ml) + MIBG (1µM) 10 50 1 2 MIBG [µM] IFN [U/ml] IFN (10U/ml) + MIBG (2µM) IFN (50U/ml) + MIBG (1µM) IFN (50U/ml) + MIBG (2µM)

More Related